- Question from MEdwards: Are any secondary cancers associated with the therapies for breast cancer long-term?
- Answers - Carol Kaplan Unfortunately, there is a risk of what we call secondary cancer related to various breast cancer therapies. However, I'd like to point out that this risk is very, very low. Specifically, chemotherapy can bring with it a small risk of bone marrow cancer or leukemia years later. This is why it's important for you to discuss the benefit-to-risk ratio of your treatment with your oncologist. Additionally, tamoxifen has a well-defined but low risk of causing what is almost always an early-stage, treatable uterine cancer. Finally, radiation therapy can bring with it a risk of soft tissue tumors down the road. I'd like to say one more time, however, that cumulatively, these risks are very low.
The Ask-the-Expert Online Conference called Updates From the 2008 ASCO Annual Meeting featured Generosa Grana, M.D., F.A.C.P. and Carol Kaplan, M.D. answering your questions about the latest research advances on screening, treatment, side effects, and more.
Editor's Note: This conference took place in June 2008.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.